talquetamab
janssen
['multiple myeloma', 'talquetamab', 'monumental-1', 'multiplemyeloma']
the monumental-1 phase 1/2 trial investigated the efficacy and safety of talquetamab for patients with relapsed/refractory multiple myeloma.
learn more about this study on medshr: #multiplemyeloma #ash22
MedShr -The App for Doctors, is a HIPAA & GMC compliant network for medical professionals to discuss clinical cases. MedShr now has over 2M members worldwide.